Works about FENOFIBRATE

Results: 702

Lipid-Lowering Efficacy and Safety of Fenofibrate and Gemfibrozil in Patients Undergoing Dialysis: A Retrospective Cohort Analysis.

Published in:

Journal of the Medical Association of Thailand, 2025, v. 108, p. S157, doi. 10.35755/jmedassocthai.2025.S01.S157-S163

By:

Kurathong, Sathit;
Trapcharoen, Viroonrat;
Jaturapisanukul, Solos;
Ngamvichukorn, Tanun;
Pongsittisak, Wanjak;
Trakarnvanich, Thananda

Publication type:

Article

Application of Solvent Evaporation to Generate Supersaturated Lipid-Based Formulations: Investigation of Drug Load and Formulation Quality.

Published in:

Pharmaceutics, 2025, v. 17, n. 6, p. 702, doi. 10.3390/pharmaceutics17060702

By:

Paulus, Felix;
Stappaerts, Jef;
Bauer-Brandl, Annette;
Lauwers, Dirk;
Smet, Liesbet;
Hermans, Eline;
Holm, René

Publication type:

Article

Conference news: Highlights from the 84th Scientific Sessions of the American Diabetes Association.

Published in:: Journal of Diabetes Nursing, 2024, v. 28, n. 4, p. 1
Publication type:: Article

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Published in:

Liver International, 2018, v. 38, n. 6, p. 1084, doi. 10.1111/liv.13634

By:

Jain, Mukul R.;
Giri, Suresh R.;
Bhoi, Bibhuti;
Trivedi, Chitrang;
Rath, Akshyaya;
Rathod, Rohan;
Ranvir, Ramchandra;
Kadam, Shekhar;
Patel, Hiren;
Swain, Prabodha;
Roy, Sib Sankar;
Das, Nabanita;
Karmakar, Eshani;
Wahli, Walter;
Patel, Pankaj R.

Publication type:

Article

Fenofibrate, a peroxisome proliferator-activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.

Published in:

Liver International, 2006, v. 26, n. 5, p. 613, doi. 10.1111/j.1478-3231.2006.01265.x

By:

Harano, Yuichi;
Yasui, Kohichiroh;
Toyama, Tetsuya;
Nakajima, Tomoki;
Mitsuyoshi, Hironori;
Mimani, Masahito;
Hirasawa, Tsutomu;
Itoh, Yoshito;
Okanoue, Takeshi

Publication type:

Article

Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells.

Published in:

Journal of Neuro-Oncology, 2014, v. 117, n. 2, p. 225, doi. 10.1007/s11060-014-1385-6

By:

Binello, Emanuela;
Mormone, Elisabetta;
Emdad, Luni;
Kothari, Harini;
Germano, Isabelle

Publication type:

Article

Fenofibrate reduces intestinal damage and improves intestinal recovery following intestinal ischemia-reperfusion injury in a rat.

Published in:

2016

By:

Sukhotnik, I.;
Nissimov, N.;
Ben Shahar, Y.;
Moati, D.;
Bitterman, N.;
Pollak, Y.;
Berkowitz, D.;
Coran, A.;
Bitterman, A.;
Coran, A G

Publication type:

journal article

Unveiling the Link Between Low Handgrip Strength and Diabetic Foot Disease in Non-Geriatric Type 2 Diabetes Patients.

Published in:

Endocrinology Research & Practice, 2024, v. 28, n. 1, p. 20, doi. 10.5152/erp.2024.23330

By:

İmre, Eren;
İmre, Erdi

Publication type:

Article

Effect of Fenofibrate as PPARα Agonist in Suppressing the Development of Oxaliplatin-Induced Peripheral Neuropathy via TRPA1 Modulation.

Published in:

Pharmacy & Pharmaceutical Sciences Journal / Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 2023, v. 10, n. 2, p. 257, doi. 10.20473/jfiki.v10i22023.257-265

By:

Aliyah, Alma Nuril;
Aprilia, Pingkan;
Sagung Dyah Pramesti, Anak Agung;
Saraya, Tarisya Dinda;
Pide, Galuh Laksatrisna;
Budi Sumartha, I Nengah;
Wongso, Luke;
Rahmadi, Mahardian;
Samirah;
Bin Ramli, Muhammad Zaki;
Ardianto, Chrismawan

Publication type:

Article

Optimization of Parameters for The Design and Evaluation of Fenofibrate Loaded Floating Microspheres by Taguchi Method.

Published in:

Journal of Research in Pharmacy, 2023, v. 27, n. 1, p. 130, doi. 10.29228/jrp.298

By:

LENO JENITA, Josephine;
AGASA RAMU, Mahesh;
SAH, Priyanka;
RATHORE, Seema S.

Publication type:

Article

Dissolution enhancement and physicochemical characterization of fenofibric acid in surface solid dispersion with croscarmellose sodium.

Published in:

Journal of Research in Pharmacy, 2019, v. 23, n. 2, p. 315, doi. 10.12991/jrp.2019.139

By:

WINDRIYATI, Yulias Ninik;
SUMIRTAPURA, Yeyet Cahyati;
PAMUDJI, Jessie Sofia

Publication type:

Article

Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.

Published in:

Drug Development & Industrial Pharmacy, 2010, v. 36, n. 9, p. 1054, doi. 10.3109/03639041003642081

By:

Zhang, Lili;
Chai, Guihong;
Zeng, Xueping;
He, Haibing;
Xu, Hui;
Tang, Xing

Publication type:

Article

In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion.

Published in:

Drug Development & Industrial Pharmacy, 2010, v. 36, n. 6, p. 681, doi. 10.3109/03639040903449720

By:

He, Haibing;
Yang, Rui;
Tang, Xing

Publication type:

Article

Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats.

Published in:

Drug Development & Industrial Pharmacy, 2009, v. 35, n. 7, p. 827, doi. 10.1080/03639040802623941

By:

Li, XueMing;
Gu, Li;
Xu, YuanLong;
Wang, YongLu

Publication type:

Article

Dissolution and Solubility Behavior of Fenofibrate in Sodium Lauryl Sulfate Solutions.

Published in:

Drug Development & Industrial Pharmacy, 2005, v. 31, n. 9, p. 917, doi. 10.1080/03639040500272108

By:

Granero, Gladys E.;
Ramachandran, Chandrasekharan;
Amidon, Gordon L.

Publication type:

Article

Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 1, p. 126, doi. 10.3390/jcm10010126

By:

Enright, Jennifer M.;
Zhang, Sheng;
Thebeau, Christina;
Siebert, Emily;
Jin, Alexander;
Gadiraju, Veda;
Zhang, Xiaodong;
Chen, Shiming;
Semenkovich, Clay F.;
Rajagopal, Rithwick

Publication type:

Article

Fenofibrate Facilitates Post-Active Tuberculosis Infection in Macrophages and is Associated with Higher Mortality in Patients under Long-Term Treatment.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 337, doi. 10.3390/jcm9020337

By:

Liu, Ching-Lung;
Lu, Yen-Ta;
Tsai, I-Fan;
Wu, Ling-Chiao;
Chien, Wu-Chien;
Chung, Chi-Hsiang;
Ma, Kuo-Hsing

Publication type:

Article

Hypertriglyceridemia and Hepatic Steatosis in Senescence-Accelerated Mouse Associate to Changes in Lipid-Related Gene Expression.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2007, v. 62, n. 11, p. 1219, doi. 10.1093/gerona/62.11.1219

By:

Vilà, Laia;
Roglans, Núria;
Alegret, Marta;
Camins, Antoni;
Pallas, Mercè;
Sánchez, Rosa María;
Vázquez-Carrera, Manuel;
Laguna, Juan Carlos

Publication type:

Article

Management of elevated serum triglycerides in type 2 diabetes: A pragmatic approach.

Published in:

Diabetes & Primary Care, 2012, v. 14, n. 4, p. 223

By:

Sinclair, Alan;
Feher, Michael;
Hobbs, Richard;
Merriman, Honor;
Nair, Devaki;
Viljoen, Adie;
Young, Ian

Publication type:

Article

Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism.

Published in:

Antioxidants, 2023, v. 12, n. 9, p. 1758, doi. 10.3390/antiox12091758

By:

Ibáñez, Cristina;
Acuña, Tirso;
Quintanilla, María Elena;
Pérez-Reytor, Diliana;
Morales, Paola;
Karahanian, Eduardo

Publication type:

Article

Hemorrhagic pancreatitis from fenofibrate and metformin toxicity: a case report.

Published in:

World Journal of Emergency Medicine, 2023, v. 14, n. 6, p. 495, doi. 10.5847/wjem.j.1920-8642.2023.106

By:

Aik Beng Lee, Marcus;
Mingwei Ng;
Yugendra, Paul;
Yiju Yao;
Ponampalam, R.;
Boon Kiat Tan, Kenneth

Publication type:

Article

MicroRNA-668 alleviates renal fibrosis through PPARα/PGC-1α pathway.

Published in:

European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-02248-x

By:

Wang, Xinran;
Gu, Zhoupeng;
Huang, Yan;
Wang, Jingyan;
Tang, Shiqi;
Yang, Xinyu;
Wang, Jianwen

Publication type:

Article

Role of fenofibrate in multiple sclerosis.

Published in:

European Journal of Medical Research, 2024, v. 29, n. 1, p. 1, doi. 10.1186/s40001-024-01700-2

By:

Abulaban, Ahmad A.;
Al-kuraishy, Hayder M.;
Al-Gareeb, Ali I.;
Elekhnawy, Engy;
Alanazi, Asma;
Alexiou, Athanasios;
Papadakis, Marios;
Batiha, Gaber El-Saber

Publication type:

Article

Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-023-00730-6

By:

Wang, Xuemei;
Wang, Jieying;
Ying, Cao;
Xing, Yuan;
Su, Xuan;
Men, Ke

Publication type:

Article

Acute cholestatic hepatitis induced by fenofibrate.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2009, v. 34, n. 5, p. 599, doi. 10.1111/j.1365-2710.2009.01029.x

By:

Hajdu, D.;
Aiglová, K.;
Vinklerová, I.;
Urbánek, K.

Publication type:

Article

Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2003, v. 28, n. 5, p. 419, doi. 10.1046/j.0269-4727.2003.00512.x

By:

Marchesi, S.;
Lupattelli, G.;
Lombardini, R.;
Roscini, A. R.;
Siepi, D.;
Vaudo, G.;
Pirro, M.;
Sinzinger, H.;
Schillaci, G.;
Mannarino, E.

Publication type:

Article

Comparison of the efficacy and safety of fenofibrate and lovastatin in patients with primary type IIa or IIb hyperlipidaemia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 1998, v. 23, n. 3, p. 213, doi. 10.1046/j.1365-2710.1998.00154.x

By:

Gholami, K.;
Tavakoli, N.;
Maleki, M.;
Shafiee, A.

Publication type:

Article

Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4583, doi. 10.1111/dom.15815

By:

Hyun, Young Youl;
Kim, Kyung‐Soo;
Hong, Sangmo;
Han, Kyungdo;
Park, Cheol‐Young

Publication type:

Article

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 385, doi. 10.1111/dom.15295

By:

Davis, Timothy M. E.;
Maxwell, Sharon;
Chan, Cathy;
Keen, Helen I.;
Davis, Wendy A.

Publication type:

Article

Uric acid predicts long‐term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1388, doi. 10.1111/dom.14046

By:

Cao, Jacob Y.;
Waldman, Boris;
O'Connell, Rachel;
Sullivan, David R.;
Scott, Russell S.;
Aryal, Nanda;
Gebski, Val;
Marschner, Ian;
Taskinen, Marja‐Riitta;
Simes, John R.;
McGill, Neil;
Jenkins, Alicia J.;
Keech, Anthony C.

Publication type:

Article

Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 9, p. 752, doi. 10.1111/j.1463-1326.2010.01229.x

By:

Chan, D. C.;
Hamilton, S. J.;
Rye, K. A.;
Chew, G. T.;
Jenkins, A. J.;
Lambert, G.;
Watts, G. F.

Publication type:

Article

Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study.

Published in:

Ophthalmic Epidemiology, 2014, v. 21, n. 5, p. 307, doi. 10.3109/09286586.2014.949783

By:

Massin, Pascale;
Peto, Tunde;
Ansquer, Jean-Claude;
Aubonnet, Patrick;
MacuFEN Study Investigators, for the

Publication type:

Article

Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II-induced hypertension in rats.

Published in:

British Journal of Pharmacology, 2007, v. 151, n. 1, p. 45, doi. 10.1038/sj.bjp.0707215

By:

De Ciuceis, C.;
Amiri, F.;
Iglarz, M.;
Cohn, J. S.;
Touyz, R. M.;
Schiffrin, E. L.

Publication type:

Article

Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study.

Published in:

British Journal of Pharmacology, 2006, v. 149, n. 7, p. 909, doi. 10.1038/sj.bjp.0706917

By:

Pierno, S.;
Didonna, M. P.;
Cippone, V.;
De Luca, A.;
Pisoni, M.;
Frigeri, A.;
Nicchia, G. P.;
Svelto, M.;
Chiesa, G.;
Sirtori, C.;
Scanziani, E.;
Rizzo, C.;
De Vito, D.;
Conte Camerino, D.

Publication type:

Article

Effects of fenofibrate therapy on renal function in primary gout patients.

Published in:

Rheumatology, 2021, v. 60, n. 11, p. 5020, doi. 10.1093/rheumatology/keab231

By:

Li, Xinde;
Sun, Wenyan;
Lu, Jie;
He, Yuwei;
Chen, Ying;
Ren, Wei;
Cui, Lingling;
Liu, Zhen;
Wang, Can;
Wang, Xuefeng;
Ma, Lidan;
Cheng, Xiaoyu;
Han, Lin;
Li, Hailong;
Zhang, Hui;
Yuan, Xuan;
Ji, Xiaopeng;
Ji, Aichang;
Merriman, Tony R;
Li, Changgui

Publication type:

Article

Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management.

Published in:

2003

By:

Dierkes, J.;
Westphal, S.;
Luley, C.;
Dierkes, Jutta;
Westphal, Sabine;
Luley, Claus

Publication type:

journal article

Dissolution enhancement of Fenofibrate tablet through Solid dispersion technique by Kneading method using various ratio of Poloxamer-188.

Published in:

International Journal of Pharmacy & Life Sciences, 2014, v. 5, n. 10, p. 3880

By:

Parvin, Shumaia;
Rafshanjani, Md. Abu Shuaib;
Kader, Md. Abdul

Publication type:

Article

THE ACTION OF STATINS AND FIBRATES ON BONE STRUCTURE AND FRACTURE HEALING PROCESS.

Published in:

Romanian Journal of Functional & Clinical, Macro & Microscopical Anatomy & of Anthropology / Revista Româna de Anatomie Functionala si Clinica, Macro si Microscopica si de Antropologie, 2012, v. 11, n. 3, p. 271

By:

Şipoş, R.-S.;
Şuş, Ioana;
Pap, Zsuzsanna;
Pávai, Z.

Publication type:

Article

A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia.

Published in:

Journal of Advanced Pharmaceutical Technology & Research, 2013, v. 4, n. 3, p. 166, doi. 10.4103/2231-4040.116778

By:

Lella, Meenakshi;
K. Indira

Publication type:

Article

Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 6, p. 7899, doi. 10.3892/mmr.2015.4466

By:

PING LI;
SHIKE LUO;
CHUNJI PAN;
XIAOSHU CHENG

Publication type:

Article

Fenofibrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway.

Published in:

Molecular Medicine Reports, 2015, v. 12, n. 4, p. 6112, doi. 10.3892/mmr.2015.4164

By:

SHUZHI ZHAO;
JUN LI;
NA WANG;
BINGQING ZHENG;
TAO LI;
QING GU;
XUN XU;
ZHI ZHENG

Publication type:

Article

Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report.

Published in:

Case Reports in Oncology, 2021, v. 14, n. 1, p. 207, doi. 10.1159/000512820

By:

Saito, Yoshitaka;
Takekuma, Yoh;
Yuki, Satoshi;
Komatsu, Yoshito;
Sugawara, Mitsuru

Publication type:

Article

Evaluation of PPARα activation by known blueberry constituents.

Published in:

Journal of the Science of Food & Agriculture, 2016, v. 96, n. 5, p. 1666, doi. 10.1002/jsfa.7269

By:

Rimando, Agnes M;
Khan, Shabana I;
Mizuno, Cassia S;
Ren, Guang;
Mathews, Suresh T;
Kim, Hyunsook;
Yokoyama, Wallace

Publication type:

Article

New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.

Published in:

Cardiovascular Therapeutics, 2015, v. 33, n. 6, p. 329, doi. 10.1111/1755-5922.12148

By:

Foucher, Christelle;
Aubonnet, Patrick;
Reichert, Petr;
Berli, Mario;
Schaeffer, Axel;
Calvo Vargas, Cesar Gonzalo;
Lochocka, Anna;
Belenky, Dmitry;
Koch, Hans‐Friedrich

Publication type:

Article

The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia.

Published in:

Cardiovascular Therapeutics, 2015, v. 33, n. 5, p. 270, doi. 10.1111/1755-5922.12139

By:

Krysiak, Robert;
Gilowski, Wojciech;
Okopien, Bogusław

Publication type:

Article

Different Effects of Fenofibrate on Metabolic and Cardiovascular Risk Factors in Mixed Dyslipidemic Women With Normal Thyroid Function and Subclinical Hypothyroidism.

Published in:

Cardiovascular Therapeutics, 2014, v. 32, n. 6, p. 264, doi. 10.1111/1755-5922.12095

By:

Krysiak, Robert;
Gilowski, Wojciech;
Szkrobka, Witold;
Okopien, Bogusław

Publication type:

Article

Effect of Switch to the Highest Dose of Rosuvastatin Versus Add-on-Statin Fenofibrate Versus Add-on-Statin Nicotinic Acid/Laropiprant on Oxidative Stress Markers in Patients with Mixed Dyslipidemia.

Published in:

Cardiovascular Therapeutics, 2014, v. 32, n. 4, p. 139, doi. 10.1111/1755-5922.12072

By:

Kei, Anastazia;
Tellis, Constantinos;
Liberopoulos, Evangelos;
Tselepis, Alexandros;
Elisaf, Moses

Publication type:

Article

Coronary Flow Velocity Reserve is Improved by PPAR-α Agonist Fenofibrate in Patients with Hypertriglyceridemia.

Published in:

Cardiovascular Therapeutics, 2013, v. 31, n. 3, p. 161, doi. 10.1111/j.1755-5922.2011.00307.x

By:

Wang, Guang;
He, Liyun;
Liu, Jinbo;
Yu, Jie;
Feng, Xinheng;
Li, Fuwang;
Hao, Yanting;
Mao, Jieming;
Hong, Tianpei;
Chen, Alex F.;
Wang, Xian

Publication type:

Article

Paradoxical Decrease in High-Density Lipoprotein Cholesterol with Fenofibrate: A Quite Rare Phenomenon Indeed.

Published in:

Cardiovascular Therapeutics, 2010, v. 28, n. 3, p. 153, doi. 10.1111/j.1755-5922.2009.00121.x

By:

Mombelli, Giuliana;
Pazzucconi, Franco;
Bondioli, Alighiero;
Zanaboni, AnnaMaria;
Gaito, Sabrina;
Calabresi, Laura;
Sirtori, Cesare R.

Publication type:

Article

Fenofibrate-induced renal dysfunction, yes or no?

Published in:

Journal of Research in Medical Sciences, 2020, v. 25, n. 4, p. 1, doi. 10.4103/jrms.JRMS_772_19

By:

Emami, Fatemeh;
Hariri, Amirali;
Matinfar, Mohammad;
Nematbakhsh, Mehdi

Publication type:

Article